Filter
1439
Text search:
drug
regimens
Featured
Recommendations
165
New Publications
351
Language
Document type
No document type
899
Guidelines
219
Studies & Reports
191
Manuals
46
Strategic & Response Plan
31
Fact sheets
23
Training Material
16
Situation Updates
7
Resource Platforms
3
Infographics
3
Online Courses
1
Countries / Regions
India
77
South Africa
45
Global
39
Kenya
38
Tanzania
34
Western and Central Europe
30
Zambia
27
Ethiopia
26
Uganda
25
Eastern Europe
25
Nepal
22
Latin America and the Carribbean
19
Nigeria
18
Malawi
18
Rwanda
17
Namibia
17
Africa
17
Asia
16
Bangladesh
14
Myanmar / Burma
14
Ukraine
13
Ghana
12
Zimbabwe
12
Philippines
12
South–East Asia Region
11
Cambodia
10
Mozambique
10
Lesotho
9
Liberia
8
Russia
8
Sierra Leone
7
Botswana
7
Cameroon
5
Haiti
5
Eswatini/ Swaziland
5
Colombia
5
Georgia
5
Senegal
4
Congo, Democratic Republic of
4
Thailand
4
East and Southern Africa
4
Venezuela
4
Albania
4
USA
3
Pakistan
3
Syria
3
Indonesia
3
Argentina
3
West and Central Africa
3
Western Pacific Region
3
Tajikistan
3
Estonia
3
Vietnam
3
Somalia
2
South Sudan
2
Germany
2
China
2
Brazil
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Bhutan
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Guinea
1
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Peru
1
North Macedonia
1
Bolivia
1
Greece
1
Chile
1
Paraguay
1
North Korea
1
Laos
1
Iran
1
Jamaica
1
Denmark
1
Tunisia
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
468
Clinical Guidelines
222
Public Health
60
Women & Child Health
52
Capacity Building
31
Key Resources
15
Pharmacy & Technologies
14
Toolboxes
HIV
309
TB
305
NTDs
62
AMR
50
Pharmacy
41
Malaria
31
NCDs
30
COVID-19
23
Mental Health
22
Ebola & Marburg
18
Refugee
18
Polio
11
Conflict
11
Caregiver
7
Disability
6
Rapid Response
6
Natural Hazards
4
Health Financing Toolbox
4
Planetary Health
3
Specific Hazards
2
Global Health Education
2
Social Ethics
2
2.0 Rapid Response
2
Cholera
1
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
International Journal of Drug Policy 24 (2013) e91-98
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequ
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in distric
...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA)
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
Open Forum Infect Dis . 2022 Apr 5;9(5):ofac148.doi: 10.1093/ofid/ofac148. eCollection 2022 May. Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral the
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the
...
